A Multicenter, Randomized, Factorial, Double-blinded, Double-dummy Phase III Trial to Evaluate the Efficacy and Safety of the Coadministration of Valsartan 160mg and Rosuvastatin 20mg in Comparison to Each Component Administered Alone in Patients With Hypertension and Hyperlipidemia
Latest Information Update: 30 Dec 2014
At a glance
- Drugs Rosuvastatin/valsartan (Primary) ; Rosuvastatin; Valsartan
- Indications Hypercholesterolaemia; Hypertension
- Focus Registrational; Therapeutic Use
- Sponsors LG Life Sciences
- 09 Aug 2013 New trial record